| Téléchargement | - Voir la version finale : Integration of multi-omics and benchmark dose modeling to support adverse outcome pathways (PDF, 2.4 Mio)
- Voir les données supplémentaires partie 1 : Integration of multi-omics and benchmark dose modeling to support adverse outcome pathways (PDF, 386 Kio)
- Voir les données supplémentaires partie 2 : Integration of multi-omics and benchmark dose modeling to support adverse outcome pathways (XLSX, 5.4 Mio)
|
|---|
| DOI | Trouver le DOI : https://doi.org/10.1080/09553002.2024.2442694 |
|---|
| Auteur | Rechercher : Vuong, Ngoc Q.; Rechercher : Khilji, Saadia; Rechercher : Williams, Andrew; Rechercher : Adam, Nadine; Rechercher : Flores, Danicia; Rechercher : Fulton, Kelly M.1; Rechercher : Baay, Isabel1; Rechercher : Twine, Susan M.1; Rechercher : Meier, Matthew J.Identifiant ORCID : https://orcid.org/0000-0001-8199-8754; Rechercher : Kumarathasan, Premkumari; Rechercher : Wilkins, Ruth C.Identifiant ORCID : https://orcid.org/0000-0002-9621-477X; Rechercher : Yauk, Carole L.Identifiant ORCID : https://orcid.org/0000-0002-6725-3454; Rechercher : Chauhan, VinitaIdentifiant ORCID : https://orcid.org/0000-0002-4498-0915 |
|---|
| Affiliation | - Conseil national de recherches Canada. Thérapeutique en santé humaine
|
|---|
| Format | Texte, Article |
|---|
| Sujet | AOPs; radiation; benchmark dosemodeling; transcriptomics; proteomics; low dose effect |
|---|
| Résumé | Background
Recent advancements in omics and benchmark dose (BMD) modeling have facilitated identifying the dose required for a predetermined change in a response (e.g. gene or protein change) that can be used to establish acceptable dose levels for hazardous exposures. Adverse Outcome Pathways (AOPs) describe the causal links between toxicants and adverse effects through key events (KEs). Integrating omics data within the AOP framework quantitatively links early molecular events to later phenotypic effects. In this study, we use omic-based BMD analyses in an in vitro blood model exposed to radiation to identify point of departure (POD) values across KEs to acute myeloid leukemia (www.aopwiki.org/aop/432).
Methods
Isolated white blood cells were cultured and X-irradiated (1 Gy/minute, 0–6 Gy). Transcriptomic and proteomic changes were assessed 24 h post-exposure. BMD modeling was applied and significantly perturbed genes/proteins and pathways were identified. Those pathways relevant to KEs outlined in AOP 432 were grouped and a POD was determined.
Results
BMD modeling identified 1294 genes and 167 proteins with median BMD lower confident limit (BMD) values of 1.35 and 0.32 Gy, respectively. Pathway analysis identified biological processes related to DNA damage/repair, oxidative stress, cell cycle regulation, immune responses, and cancer development. These findings aligned with the KEs in AOP 432. The BMDL values of canonical pathways associated with these KEs were generally below 0.5 Gy with specific genes (e.g. GADD45A) displaying BMDLs <0.05 Gy.
Conclusions
This work provides insights into predictive radiation induced mechanisms and associated dose of activity that can be taken into consideration for low dose (< 0.1 Gy) risk analysis. |
|---|
| Date de publication | 2025-01-02 |
|---|
| Maison d’édition | Taylor & Francis |
|---|
| Licence | |
|---|
| Dans | |
|---|
| Langue | anglais |
|---|
| Publications évaluées par des pairs | Oui |
|---|
| Exporter la notice | Exporter en format RIS |
|---|
| Signaler une correction | Signaler une correction (s'ouvre dans un nouvel onglet) |
|---|
| Identificateur de l’enregistrement | aff6c13c-e683-4287-8750-ad0f7215769c |
|---|
| Enregistrement créé | 2025-06-27 |
|---|
| Enregistrement modifié | 2025-06-27 |
|---|
